Literature DB >> 8741242

A case report of angioedema during long-term (66 months) angiotensin converting enzyme inhibition therapy with enalapril.

H Shionoiri1, I Takasaki, N Hirawa, M Kihara, E Gotoh, T Sasaki, H Nakajima, M Ishii.   

Abstract

We describe a rare case of ACE inhibitor-induced angioedema during long-term therapy in a 51-year-old male patient with essential hypertension; and this is the third case reported of this adverse reaction in Japan. The patient received enalapril for 66 months, and complained of a dry cough which was mild and tolerable. Recently, he noted tenderness of his mouth, face, swelling of lips and tongue for 3 to 4 h after taking his morning dose of enalapril. These symptoms abated spontaneously, so he continued taking the drugs. He again noted similar episodes of angioedema 29 days after the first experience. He had no further episodes of angioedema or dry cough after cessation of enalapril. This case of angioedema developed during long-term therapy with enalapril administered as 19,930 mg of enalapril maleate. We emphasize that angioedema may occur at any time during the use of enalapril.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8741242     DOI: 10.1253/jcj.60.166

Source DB:  PubMed          Journal:  Jpn Circ J        ISSN: 0047-1828


  4 in total

Review 1.  Pathogenesis, newly recognized etiologies, and management of idiopathic anaphylaxis.

Authors:  James L Kuhlen; Yamini V Virkud
Journal:  Discov Med       Date:  2015-02       Impact factor: 2.970

Review 2.  ACE inhibitor-induced angioedema. Incidence, prevention and management.

Authors:  W Vleeming; J G van Amsterdam; B H Stricker; D J de Wildt
Journal:  Drug Saf       Date:  1998-03       Impact factor: 5.606

3.  Delayed presentation of ACE inhibitor-induced angio-oedema.

Authors:  Guy Amey; Pasan Waidyasekara; Ramanathan Kollengode
Journal:  BMJ Case Rep       Date:  2013-07-29

Review 4.  Current concepts of pharmacotherapy in hypertension: ACE inhibitor-related angioedema: can angiotensin-receptor blockers be safely used?

Authors:  Domenic A Sica; Henry R Black
Journal:  J Clin Hypertens (Greenwich)       Date:  2002 Sep-Oct       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.